XIX International AIDS Conference in Washington D.C. Barton Haynes from the Duke Human Vaccine Institute (DHVI) has been working in the HIV vaccine field since 1985. Here he talks about the scientific difficulties of finding an HIV vaccine.

XVII International AIDS Conference in Mexico City. American HIV/AIDS pioneer Dr Anthony Fauci from the National Institute of Allergy and Infectious Diseases (NIAID) talks about the disappointments of the latest HIV vaccine trials, and the leadership of Peter Piot.

XVII International AIDS Conference in Mexico City. American HIV/AIDS pioneer Dr Anthony Fauci from the National Institute of Allergy and Infectious Diseases (NIAID) talks about the disappointments of the latest HIV vaccine trials, and the leadership of Peter Piot.

This film tells the US story of the AIDS epidemic starting in the early 1980's. Scientists and activists, both pioneers and youths of today, talk about research, prevention, treatment and care. They also discuss stigma, homophobia and poverty as closely related to HIV and AIDS.

In the last part of the interview with Dr Anthony Fauci he reflects on the global HIV/AIDS situation and response. He also compares AIDS to other diseases such as the Bird Flu, and discusses the specific social and socioeconomic factors of HIV/AIDS.

This is the third part of the interview with Dr Anthony Fauci. Here he talks about the American AIDS movement in the early 80's with activists such as the writer Larry Kramer in the frontline, and the time when he invited the leading activists up to his office.

Anthony Fauci is interviewed about the progression from HIV to AIDS. He talks about HIV long-term survivors and different aspects of non-progression to AIDS. He also reflects on the future for antiretroviral drugs and HIV vaccines.

Dr George Galasso is working on HIV vaccines at NIAID. Here he talks about the scientific challenges of HIV/AIDS and the chances of developing a vaccine. He believes that one of the main focuses in HIV/AIDS research still is to find treatment for opportunistic infections.